Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Roger Stupp MD
Roger Stupp MD Advisory Board
Rafael Fonseca MD
Rafael Fonseca MD Editor-in-Chief
Guru Sonpavde MD
Guru P. Sonpavde MD Advisory Board
See All Experts
Published in Oncology

News · February 01, 2024

ASCO GU 2024: Cabozantinib Plus Atezolizumab Combination Therapy Effective for mCRPC Patients

Radiographic progression-free survival 6.3 months among those receiving the combination therapy

PracticeUpdate Editorial Team

 

 Save  Recommend
 Share

Further Reading

Most Read This Week

Recently Updated